NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

泌尿道感染治療的全球市場 - 至2027年的預測:COVID-19的影響及各藥物類別、適應症、流通管道、地區的分析

Urinary Tract Infection Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class, Indication, Distribution Channel, and Geography

出版商 The Insight Partners 商品編碼 983297
出版日期 內容資訊 英文 241 Pages
訂單完成後即時交付
價格
泌尿道感染治療的全球市場 - 至2027年的預測:COVID-19的影響及各藥物類別、適應症、流通管道、地區的分析 Urinary Tract Infection Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class, Indication, Distribution Channel, and Geography
出版日期: 2020年11月30日內容資訊: 英文 241 Pages
簡介

全球泌尿道感染治療的市場規模,從2019年的91億640萬平美元,預計2027年達到116億1432萬美元,從2020年到2027年以3.2%的年複合成長率成長。市場成長,起因於泌尿道感染的盛行率上升,人口的高齡化,尿診斷的新運算技術等幾個要素。但,醫藥品的副作用,新興國家的產品的認識不足,預計在預測期間內裡某種程度妨礙市場成長。

本報告提供全球泌尿道感染治療市場相關調查分析,各市場區隔、各地區的市場分析與預測,市場發展的影響要素,COVID-19大流行給市場的影響,競爭情形,主要企業的簡介等相關的系統性資訊。

目錄

第1章 簡介

第2章 泌尿道感染治療市場:要點

第3章 調查手法

第4章 全球泌尿道感染治療市場:市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 泌尿道感染治療市場:主要的市場動態

  • 促進市場成長因素
  • 阻礙市場成長要素
  • 市場機會
  • 未來趨勢
  • 影響分析

第6章 泌尿道感染治療:全球市場分析

  • 世界市場收益預測及分析
  • 全球市場:各地區的預測及分析
  • 主要企業的市場定位

第7章 泌尿道感染治療市場分析:各醫藥品分類

  • 概要
  • 市場收益佔有率:各醫藥品分類
  • 青霉素、複合藥
  • 奎諾酮類抗生素(Quinolones)
  • 頭孢菌素
  • Aminoglycosides系抗生素
  • 磺胺類藥物
  • 營養補充品

第8章 泌尿道感染治療市場分析:各適應症

  • 概要
  • 市場收益佔有率:各適應症
  • 複雜性泌尿道感染
  • 單純性泌尿道感染

第9章 泌尿道感染治療市場分析:各流通管道

  • 概要
  • 市場收益佔有率:各流通管道
  • 醫院藥局
  • 零售藥局&藥妝店
  • 婦產科、泌尿科診所
  • 網路藥店

第10章 泌尿道感染治療市場分析:地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第11章 COVID-19大流行對全球泌尿道感染治療市場的影響

  • 北美:COVID-19大流行的影響評估
  • 歐洲:COVID-19大流行的影響評估
  • 亞太地區:COVID-19大流行的影響評估
  • 其他地區:COVID-19大流行的影響評估

第12章 產業形勢的展望

  • 概要
  • 成長策略:各企業
  • 有機的開發
  • 無機的開發
目錄
Product Code: TIPRE00005931

The market is expected to reach US$ 11,614.32 million in 2027 from US$ 9,106.40 million in 2019. The market is estimated to grow with a CAGR of 3.2% from 2020-2027. The growth of the market is attributed to some key driving factors such as growing prevalence of urinary tract infections, aging population and emerging computing technologies for urine diagnostics. However, lack of product awareness in emerging countries along with associated effects of medication is expected to obstruct the growth of the market to a certain extent during the forecast years.

Urinary tract infection (UTI) is an infection of the lower or upper urinary tract and occurs due to colonization of microbial pathogens in bladder or kidneys. The common symptoms of UTI are pain with urination, high frequency of urination, and urge of urination despite having an empty bladder. UTI is more common among women than men as their urethra is comparatively smaller. There are two types of urinary tract infections: complicated urinary tract infection and uncomplicated urinary tract infection.

Emerging technologies such as remote patient monitoring, artificial intelligence (AI), mobile technologies, and natural language processing are expected to enhance the efficiency of diagnostic procedures. A majority of the industry players focus on the development and distribution of advanced kits and equipment with an aim to improvise the process of home diagnostics. For instance, in May 2019, Scanwell Health launched an at-home smartphone-enabled test and treatment service for UTIs in the US. This is now available in all 50 states.

Novartis Venture Fund and Hikma Ventures in collaboration with Lemonaid Health, a telehealth company developed an easy application to get care for conditions like acid reflux, erectile dysfunction, flu, hair loss, urinary tract infections (UTIs) and for birth control medication. Moreover, the company has raised ~US$ 3.5 million to develop technologically advanced UTI diagnostics. Furthermore, in July 2019, Tel-Aviv, an Israel-based AI start-up announced the launch of its technology-enabled Dip UTI test kits in the UK. Emerging technologies for accurate and timely diagnosis would increase the number of diagnosed cases and help treat patients effectively, thereby driving the urinary tract infection treatment market.

Based on drug class, the quinolones segment held the largest share of the market in 2019; however, the penicillin and combination segment is anticipated to register the highest CAGR of 4.5% in the market during the forecast period. Quinolones drug class segment is expected to show robust growth over forecast period as the physicians most commonly prescribe it. Ciprofloxacin, levofloxacin, and enoxacin are among the most widely used drugs for treatment.

The COVID-19 pandemic was first reported in December 2019 in Wuhan (China). The impacts of this outbreak are being felt across several markets in the world. The demand for urinary tract infection treatment solutions has reduced amid this global crisis due to a significant shift in the focus toward the management, treatment, and prevention of COVID-19. The pandemic continues to worsen, causing massive disruptions in the global supply chains, consumer markets, and economies, and these conditions are also restraining the growth of the urinary tract infection treatment market.

The Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Union (EU), Organization for Economic Co-operation and Development, Southern Africa Development Community, American Academy of Dermatology Association, US Food and Drug Administration (FDA), and National Health Service (NHS) are a few of the prime secondary sources referred to while preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the urinary tract infection treatment market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global urinary tract infection treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Urinary Tract Infection Treatment Market - By Drug Class
    • 1.3.2 Global Urinary Tract Infection Treatment Market - By Indication
    • 1.3.3 Global Urinary Tract Infection Treatment Market - By Distribution Channel
    • 1.3.4 Global Urinary Tract Infection Treatment Market - By Geography

2. Urinary Tract Infection Treatment Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Urinary Tract Infection Treatment Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America- PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa
    • 4.2.5 South & Central America
  • 4.3 Expert Opinion

5. Urinary Tract Infection Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Urinary Tract Infections
    • 5.1.2 Aging Population
    • 5.1.3 Emerging Computing Technologies for Urine Diagnostics
  • 5.2 Market Restraints
    • 5.2.1 Associated Effects of Medication
  • 5.3 Market Opportunities
    • 5.3.1 R&D in UTI Treatment
  • 5.4 Future Trends
    • 5.4.1 Nutritional Supplement in UTI
  • 5.5 Impact Analysis

6. Urinary Tract Infection Treatment Market - Global Analysis

  • 6.1 Global Urinary Tract Infection Treatment Market Revenue Forecast and Analysis
  • 6.2 Global Urinary Tract Infection Treatment Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Urinary Tract Infection Treatment Market Analysis - By Drug Class

  • 7.1 Overview
  • 7.2 Urinary Tract Infection Treatment Market Revenue Share, by Drug Class (2019 and 2027)
  • 7.3 Penicillin and Combinations
    • 7.3.1 Overview
    • 7.3.2 Penicillin and Combinations: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.3 Amoxicillin
      • 7.3.3.1 Overview
      • 7.3.3.2 Amoxicillin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.4 Amoxicillin and Clavulanate Potassium
      • 7.3.4.1 Overview
      • 7.3.4.2 Amoxicillin and Clavulanate Potassium: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.3.5 Others
      • 7.3.5.1 Overview
      • 7.3.5.2 Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Quinolones
    • 7.4.1 Overview
    • 7.4.2 Quinolones: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.4.3 Ciprofloxaxin
      • 7.4.3.1 Overview
      • 7.4.3.2 Ciprofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.4.4 Levofloxaxin
      • 7.4.4.1 Overview
      • 7.4.4.2 Levofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.4.5 Nalidixic Acid
      • 7.4.5.1 Overview
      • 7.4.5.2 Nalidixic Acid: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.4.6 Norfloxacin
      • 7.4.6.1 Overview
      • 7.4.6.2 Norfloxacin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.4.7 Others
      • 7.4.7.1 Overview
      • 7.4.7.2 Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Cephalosporin
    • 7.5.1 Overview
    • 7.5.2 Cephalosporin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Aminoglycoside Antibiotics
    • 7.6.1 Overview
    • 7.6.2 Aminoglycoside Antibiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Sulphonamides
    • 7.7.1 Overview
    • 7.7.2 Sulphonamides: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Nutritional Supplements
    • 7.8.1 Overview
    • 7.8.2 Nutritional Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.8.3 Cranberry Supplements
      • 7.8.3.1 Overview
      • 7.8.3.2 Cranberry Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.8.4 D-Mannose
      • 7.8.4.1 Overview
      • 7.8.4.2 D-Mannose: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.8.5 Probiotics
      • 7.8.5.1 Overview
      • 7.8.5.2 Probiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.8.6 Vitamin-C
      • 7.8.6.1 Overview
      • 7.8.6.2 Vitamin-C: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 7.8.7 Others
      • 7.8.7.1 Overview
      • 7.8.7.2 Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)

8. Urinary Tract Infection Treatment Market Analysis - By Indication

  • 8.1 Overview
  • 8.2 Urinary Tract Infection Treatment Market Revenue Share, by Indication (2019 and 2027)
  • 8.3 Complicated Urinary Tract Infections
    • 8.3.1 Overview
    • 8.3.2 Complicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Uncomplicated Urinary Tract Infections
    • 8.4.1 Overview
    • 8.4.2 Uncomplicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)

9. Urinary Tract Infection Treatment Market Analysis - By Distribution Channel

  • 9.1 Overview
  • 9.2 Urinary Tract Infection Treatment Market Revenue Share, by Distribution Channel (2019 and 2027)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Retail Pharmacies & Drug Stores
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Gynaecology and Urology Clinics
    • 9.5.1 Overview
    • 9.5.2 Gynaecology and Urology Clinics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Online Drug Stores
    • 9.6.1 Overview
    • 9.6.2 Online Drug Stores: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)

10. Urinary Tract Infection Treatment Market - Geographic Analysis

  • 10.1 North America: Urinary Tract Infection Treatment Market
    • 10.1.1 Overview
    • 10.1.2 North America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.1 North America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.2 North America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.3 North America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.1.7.2.1 US: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.7.2.2 US: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.7.2.3 US: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 US: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.1.8.2.1 Canada: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.8.2.2 Canada: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.8.2.3 Canada: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Canada: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.1.9.2.1 Mexico: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.9.2.2 Mexico: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.9.2.3 Mexico: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 Mexico: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.2 Europe: Urinary Tract Infection Treatment Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.2.3.1 Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.3.2 Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.3.3 Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.2.5 Europe: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Europe: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.2.7.2.1 Germany: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.7.2.2 Germany: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.7.2.3 Germany: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 Germany: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.4 Germany: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 UK: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.2.8.2.1 UK: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.8.2.2 UK: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.8.2.3 UK: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 UK: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.4 UK: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 France: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.2.9.2.1 France: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.9.2.2 France: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.9.2.3 France: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 France: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.4 France: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 Spain: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.2.10.2.1 Spain: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.10.2.2 Spain: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.10.2.3 Spain: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 Spain: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.4 Spain: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Italy: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.2.11.2.1 Italy: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.11.2.2 Italy: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.11.2.3 Italy: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Italy: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.4 Italy: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.12 Rest of Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.1 Rest of Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.2 Rest of Europe: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.2.12.2.1 Rest of Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.12.2.2 Rest of Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.12.2.3 Rest of Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.3 Rest of Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.4 Rest of Europe: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Asia Pacific: Urinary Tract Infection Treatment Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.3.3.1 Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.3.2 Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.3.3 Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.3.5 Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Asia Pacific: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 China: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.7.3.1 China: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.7.3.2 China: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.7.3.3 China: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.4 China: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.5 China: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 Japan: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.8.2.1 Japan: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.8.2.2 Japan: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.8.2.3 Japan: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 Japan: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.4 Japan: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 India: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.9.2.1 India: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.9.2.2 India: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.9.2.3 India: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 India: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.4 India: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.10 South Korea: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.10.2.1 South Korea: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.10.2.2 South Korea: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.10.2.3 South Korea: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.3 South Korea: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.4 South Korea: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.11 Australia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.11.2.1 Australia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.11.2.2 Australia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.11.2.3 Australia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.4 Australia: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.12 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.1 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.2 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.12.2.1 Rest of Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.12.2.2 Rest of Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.12.2.3 Rest of Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.3 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.4 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.4 Middle East & Africa: Urinary Tract Infection Treatment Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.4.3.1 Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.3.2 Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.3.3 Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East & Africa: Urinary Tract Infection Treatment Market, by Country, 2018 & 2027 (%)
    • 10.4.7 Saudi Arabia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.4.7.2.1 Saudi Arabia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.7.2.2 Saudi Arabia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.7.2.3 Saudi Arabia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 Saudi Arabia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 Saudi Arabia: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 UAE: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.4.8.2.1 UAE: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.8.2.2 UAE: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.8.2.3 UAE: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 UAE: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 UAE: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.4.9.2.1 South Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.9.2.2 South Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.9.2.3 South Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.3 South Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.4 South Africa: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.10 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.1 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.2 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.4.10.2.1 Rest of Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.10.2.2 Rest of Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.10.2.3 Rest of Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.3 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.4 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Urinary Tract Infection Treatment Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.5.3.1 South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.3.2 South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.3.3 South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.5.7.2.1 Brazil: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.7.2.2 Brazil: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.7.2.3 Brazil: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.4 Brazil: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Argentina: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.5.8.2.1 Argentina: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.8.2.2 Argentina: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.8.2.3 Argentina: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.4 Argentina: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.9 Rest of South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.1 Rest of South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.2 Rest of South and Central America: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.5.9.2.1 Rest of South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.9.2.2 Rest of South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.9.2.3 Rest of South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.3 Rest of South and Central America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.4 Rest of South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Urinary Tract Infection Treatment Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Urinary Tract Infection Treatment Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

List Of Tables

  • Table 1. North America: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 6. North America: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 7. US: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 8. US: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 9. US: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 10. US: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 11. US: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 12. US: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 13. Canada: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 14. Canada: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Canada: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Canada: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Canada: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Canada: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 19. Mexico: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 20. Mexico: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Mexico: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Mexico: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Mexico: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 24. Mexico: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 25. Europe: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 26. Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Europe: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 31. Germany: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 32. Germany: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Germany: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Germany: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Germany: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Germany: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 37. UK: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 38. UK: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. UK: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 40. UK: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 41. UK: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 42. UK: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 43. France: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 44. France: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 45. France: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 46. France: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 47. France: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 48. France: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 49. Spain: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 50. Spain: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Spain: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Spain: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Spain: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Spain: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 55. Italy: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 56. Italy: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 57. Italy: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 58. Italy: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 59. Italy: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 60. Italy: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 61. Rest of Europe: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 62. Rest of Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Rest of Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Rest of Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Rest of Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Rest of Europe: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 67. Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 68. Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 73. China: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 74. China: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 75. China: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 76. China: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 77. China: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 78. China: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 79. Japan: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 80. Japan: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 81. Japan: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 82. Japan: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 83. Japan: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 84. Japan: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 85. India: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 86. India: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 87. India: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 88. India: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 89. India: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 90. India: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 91. South Korea: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 92. South Korea: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 93. South Korea: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 94. South Korea: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 95. South Korea: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 96. South Korea: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 97. Australia: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 98. Australia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 99. Australia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 100. Australia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 101. Australia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 102. Australia: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 103. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 104. Rest of Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 105. Rest of Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 106. Rest of Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 107. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 108. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 109. Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 110. Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 111. Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 112. Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 113. Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 114. Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 115. Saudi Arabia: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 116. Saudi Arabia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 117. Saudi Arabia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 118. Saudi Arabia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 119. Saudi Arabia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 120. Saudi Arabia: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 121. UAE: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 122. UAE: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 123. UAE: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 124. UAE: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 125. UAE: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 126. UAE: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 127. South Africa: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 128. South Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 129. South Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 130. South Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 131. South Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 132. South Africa: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 133. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 134. Rest of Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 135. Rest of Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 136. Rest of Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 137. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 138. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 139. South and Central America: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 140. South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 141. South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 142. South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 143. South and Central America: Urinary Tract Infection Treatment Market, by Indication- Revenue and Forecast to 2027 (USD Million)
  • Table 144. South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 145. Brazil: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 146. Brazil: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 147. Brazil: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 148. Brazil: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 149. Brazil: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 150. Brazil: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 151. Argentina: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 152. Argentina: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 153. Argentina: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 154. Argentina: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 155. Argentina: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 156. Argentina: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 157. Rest of South and Central America: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 158. Rest of South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 159. Rest of South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 160. Rest of South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 161. Rest of South and Central America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 162. Rest of South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 163. Organic Developments Done By Companies
  • Table 164. Inorganic Developments Done By Companies
  • Table 165. Glossary of Terms, Urinary Tract Infection Treatment Market

List Of Figures

  • Figure 1. Urinary Tract Infection Treatment Market Segmentation
  • Figure 2. Urinary Tract Infection Treatment Segmentation, By Region
  • Figure 3. Global Urinary Tract Infection Treatment Market Overview
  • Figure 4. Quinolones Segment Held Largest Share of Urinary Tract Infection Treatment Market
  • Figure 5. APAC to Show Remarkable Growth During Forecast Period
  • Figure 6. Global Urinary Tract Infection Treatment Market, by Geography (US$ Million)
  • Figure 7. Global Urinary Tract Infection Treatment Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Urinary Tract Infection Treatment Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Expert Opinion
  • Figure 15. Urinary Tract Infection Treatments Market Impact Analysis of Drivers and Restraints
  • Figure 16. Global Urinary Tract Infection Treatment Market - Revenue Forecast and Analysis - 2019- 2027
  • Figure 17. Global Urinary Tract Infection Treatment Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 18. Market Positioning of Key Players in Global Urinary Tract Infection Treatment Market
  • Figure 19. Urinary Tract Infection Treatment Market Revenue Share, by Drug Class (2019 and 2027)
  • Figure 20. Penicillin and Combinations: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Amoxicillin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Amoxicillin and Clavulanate Potassium: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Quinolones: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Ciprofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Levofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Nalidixic Acid: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Norfloxacin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Cephalosporin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Aminoglycoside Antibiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Sulphonamides: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Nutritional Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. Cranberry Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 35. D-Mannose: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 36. Probiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 37. Vitamin-C: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 38. Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 39. Urinary Tract Infection Treatment Market Revenue Share, by Indication (2019 and 2027)
  • Figure 40. Complicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 41. Uncomplicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 42. Urinary Tract Infection Treatment Market Revenue Share, by Drug Class (2019 and 2027)
  • Figure 43. Hospital Pharmacies: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 44. Retail Pharmacies & Drug Store: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 45. Gynaecology and Urology Clinics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 46. Online Drug Stores: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 47. North America: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 48. North America Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 49. North America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 50. US: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Canada: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Mexico: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Europe: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 54. Europe Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Europe: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 56. Germany: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. UK: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. France: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Spain: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Italy: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Rest of Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 62. Asia Pacific: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 63. Asia Pacific Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 64. Asia Pacific: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 65. China: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Japan: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. India: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 68. South Korea: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 69. Australia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 70. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 71. Middle East & Africa: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 72. Middle East & Africa Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 73. Middle East & Africa: Urinary Tract Infection Treatment Market, by Country, 2018 & 2027 (%)
  • Figure 74. Saudi Arabia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 75. UAE: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 76. South Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 77. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 78. South and Central America: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 79. South and Central America Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 80. South and Central America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 81. Brazil: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 82. Argentina: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 83. Rest of South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 84. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 85. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 86. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 87. Impact of COVID-19 Pandemic in North American Country Market
  • Figure 88. Growth Strategies Done by the Companies in the Market, (%)